TNF and plasma cell myeloma: Since TNF is typically expressed by immune cells present in the tumor microenvironment of myeloma cells and other cancer entities, we explored the possibility of a synergistic cytotoxic effect of soluble recombinant TNF and MLN4924 on a panel of 10 myeloma cell lines.